Hye‐Ryun Kang

7.6k citations
237 papers · 4.6k indexed · h-index 35
Topics
Drug-Induced Adverse Reactions (95 papers)Asthma and respiratory diseases (63 papers)Contact Dermatitis and Allergies (39 papers)

In The Last Decade

Hye‐Ryun Kang

222 papers receiving 4.6k citations

Peers

Hye‐Ryun Kang
Comparison fields: 5 of 138
  • Pharmacology 1.7k
  • Physiology 930
  • Immunology and Allergy 851
  • Pulmonary and Respiratory Medicine 796
  • Dermatology 755
Replace Heung‐Woo Park with:
Heung‐Woo Park South Korea
Bernard Yu‐Hor Thong Singapore
Paul‐Michel Mertès France
Mario Sánchez‐Borges Venezuela
Kyung-Up Min South Korea
Hee‐Bom Moon South Korea
Jean‐Claude Roujeau France
Antonino Romano Italy
You Sook Cho South Korea
Anne K. Ellis Canada
Hye‐Ryun Kang relative to Heung‐Woo Park South Korea Heung‐Woo Park's profile →
Citations per field
00.5×1.5×
Heung‐Woo Park · 1×
Citations per year

Countries citing papers authored by Hye‐Ryun Kang

Since Specialization
Citations

This map shows the geographic impact of Hye‐Ryun Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye‐Ryun Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye‐Ryun Kang more than expected).

Fields of papers citing papers by Hye‐Ryun Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye‐Ryun Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye‐Ryun Kang. The network helps show where Hye‐Ryun Kang may publish in the future.

Co-authorship network of co-authors of Hye‐Ryun Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Hye‐Ryun Kang. A scholar is included among the top collaborators of Hye‐Ryun Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hye‐Ryun Kang. Hye‐Ryun Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 9
3 7
4 5
5 10
6 27
7 19
8 10
9 35
10 8
11 18
12 23
13 3
14 20
15 20
16 84
17 4
18 73
19 32
20 1

About Hye‐Ryun Kang

Hye‐Ryun Kang is a scholar working on Immunology and Allergy, Toxicology and Dermatology, having authored 237 papers that have together received 4.6k indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (95 papers), Asthma and respiratory diseases (63 papers) and Contact Dermatitis and Allergies (39 papers). The work is most often cited by research in Immunology and Allergy (851 citations), Pharmacology (1.7k citations) and Toxicology (343 citations). Hye‐Ryun Kang has collaborated with scholars based in South Korea, Ethiopia and United States. Frequent co-authors include Sang‐Heon Cho, Jae‐Woo Jung, Heung‐Woo Park, Chun Geun Lee, Jack A. Elias, Kyung-Up Min, Robert Homer, Sae‐Hoon Kim, Yoon‐Seok Chang and Woo‐Jung Song. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026